- Home
- FORR vs CATX Comparison
FORR vs CATX Comparison
Compare FORR & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORR
- CATX
- Stock Information
- Founded
- FORR 1983
- CATX 1983
- Country
- FORR United States
- CATX United States
- Employees
- FORR N/A
- CATX N/A
- Industry
- FORR Diversified Commercial Services
- CATX Medical/Dental Instruments
- Sector
- FORR Consumer Discretionary
- CATX Health Care
- Exchange
- FORR Nasdaq
- CATX Nasdaq
- Market Cap
- FORR 200.2M
- CATX 239.0M
- IPO Year
- FORR 1996
- CATX N/A
- Fundamental
- Price
- FORR $11.21
- CATX $3.29
- Analyst Decision
- FORR
- CATX Strong Buy
- Analyst Count
- FORR 0
- CATX 11
- Target Price
- FORR N/A
- CATX $12.90
- AVG Volume (30 Days)
- FORR 79.8K
- CATX 727.5K
- Earning Date
- FORR 11-04-2025
- CATX 11-11-2025
- Dividend Yield
- FORR N/A
- CATX N/A
- EPS Growth
- FORR N/A
- CATX N/A
- EPS
- FORR N/A
- CATX N/A
- Revenue
- FORR $412,103,000.00
- CATX $1,235,000.00
- Revenue This Year
- FORR N/A
- CATX N/A
- Revenue Next Year
- FORR $1.51
- CATX N/A
- P/E Ratio
- FORR N/A
- CATX N/A
- Revenue Growth
- FORR N/A
- CATX N/A
- 52 Week Low
- FORR $8.50
- CATX $1.60
- 52 Week High
- FORR $19.74
- CATX $14.19
- Technical
- Relative Strength Index (RSI)
- FORR 72.67
- CATX 45.27
- Support Level
- FORR $9.76
- CATX $3.02
- Resistance Level
- FORR $10.69
- CATX $3.74
- Average True Range (ATR)
- FORR 0.40
- CATX 0.25
- MACD
- FORR 0.16
- CATX -0.01
- Stochastic Oscillator
- FORR 83.41
- CATX 32.53
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.